[{"Assets_0_Q2_USD":113608000.0,"CommonStockSharesOutstanding_0_Q2_shares":41477420.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24353000.0,"NetIncomeLoss_1_Q2_USD":-14443000.0,"NetIncomeLoss_2_Q2_USD":-26944000.0,"StockholdersEquity_0_Q2_USD":101733000.0,"Ticker":"ISEE","CIK":"1410939","name":"IVERIC BIO, INC.","OfficialName":"IVERIC bio Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1851737728.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]